NCT01368705

Brief Summary

The objective is to the amount of protein infants require after cardiopulmonary bypass surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Aug 2009

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 8, 2011

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

August 19, 2013

Status Verified

August 1, 2013

Enrollment Period

2.8 years

First QC Date

June 6, 2011

Last Update Submit

August 16, 2013

Conditions

Keywords

InfantsNitrogen BalanceCardiothoracic surgeryCongenital heart diseaseMalnutrition

Outcome Measures

Primary Outcomes (1)

  • Nitrogen Balance

    After an initial adaptation period of approximately 12 hours receiving parenteral nutrition the first 24-hour urine collection for nitrogen balance will be started; following this two successive 24-hour urine collections will be performed in order to obtain a three-day collection for nitrogen balance analyses.

    From 0-84 hours

Study Arms (3)

Control Group

ACTIVE COMPARATOR
Dietary Supplement: Standard protein delivery

Intervention Group 1

EXPERIMENTAL
Dietary Supplement: Intervention 1 (2.2g/kg/day)

Intervention Group 2

EXPERIMENTAL
Dietary Supplement: Intervention 2 (3.0 g/kg/day)

Interventions

Standard protein deliveryDIETARY_SUPPLEMENT

Protein delivery of 1.5 g/kg/day.

Control Group

protein delivery of 2.2g/kg/day

Intervention Group 1

protein delivery of 3.0 g/kg/day

Intervention Group 2

Eligibility Criteria

Age1 Day - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical decision to initiate parenteral nutrition based on determination by medical team
  • Gestational age ≥ 35 weeks
  • Birth weight ≥ 2000 grams
  • Indwelling urinary catheters for urine collection
  • Central venous access for parenteral nutrition

You may not qualify if:

  • Chromosomal abnormalities known to effect protein metabolism
  • Hepatic failure defined as ALT and AST \> 500 UL with an INR \> 2.5, not accounted for by therapeutic anticoagulation
  • Renal failure defined as creatinine 2x the upper limit of normal for age.
  • Sepsis or suspected sepsis, defined as clinical suspicion or confirmation of a systemic infection treated with antibiotics
  • Excessive blood loss from chest tubes (5 ml/kg/hr) that has not resolved within six hours following admission to the CCCU; as indicated by the need for frequent blood transfusion these subjects will be withdrawn from the study
  • Requiring Extra Corporeal Membrane Oxygenation (ECMO) support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5V 1B2, Canada

Location

MeSH Terms

Conditions

Heart Defects, CongenitalMalnutrition

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Paul B Pencharz, MD

    The Hospital for Sick Children, Toronto, Canada

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Emeritus Scientist

Study Record Dates

First Submitted

June 6, 2011

First Posted

June 8, 2011

Study Start

August 1, 2009

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

August 19, 2013

Record last verified: 2013-08

Locations